| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
|
J Natl Cancer Inst
|
2011
|
6.11
|
|
2
|
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
|
Clin Cancer Res
|
2005
|
5.70
|
|
3
|
Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions.
|
Clin Cancer Res
|
2013
|
2.29
|
|
4
|
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.
|
Clin Cancer Res
|
2004
|
2.17
|
|
5
|
Standardization of HER2 testing: results of an international proficiency-testing ring study.
|
Mod Pathol
|
2007
|
1.69
|
|
6
|
Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients.
|
J Clin Oncol
|
2009
|
1.38
|
|
7
|
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
|
J Clin Oncol
|
2008
|
1.33
|
|
8
|
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).
|
Diagn Pathol
|
2008
|
1.17
|
|
9
|
Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.
|
J Thorac Oncol
|
2009
|
1.15
|
|
10
|
Prophylactic oophorectomy: a morphologic and immunohistochemical study.
|
Cancer
|
2003
|
1.06
|
|
11
|
Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification.
|
Clin Cancer Res
|
2007
|
1.04
|
|
12
|
Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
|
Int J Oncol
|
2002
|
1.01
|
|
13
|
HER-2 amplification is highly homogenous in gastric cancer.
|
Hum Pathol
|
2009
|
0.99
|
|
14
|
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
|
J Thorac Oncol
|
2014
|
0.98
|
|
15
|
Epigenetic modifications in prostate cancer.
|
Epigenomics
|
2014
|
0.93
|
|
16
|
Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH).
|
Mod Pathol
|
2012
|
0.91
|
|
17
|
Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.
|
PLoS One
|
2011
|
0.88
|
|
18
|
Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.
|
Breast
|
2011
|
0.86
|
|
19
|
Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk.
|
Int J Gynecol Cancer
|
2009
|
0.86
|
|
20
|
Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
|
Cancer Invest
|
2009
|
0.83
|
|
21
|
The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
|
BMC Cancer
|
2014
|
0.83
|
|
22
|
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
|
Lung Cancer
|
2005
|
0.82
|
|
23
|
P-gp expression in brown trout erythrocytes: evidence of a detoxification mechanism in fish erythrocytes.
|
Sci Rep
|
2013
|
0.80
|
|
24
|
Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.
|
Mod Pathol
|
2008
|
0.78
|
|
25
|
Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats.
|
J Peripher Nerv Syst
|
2005
|
0.78
|
|
26
|
Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions--response.
|
Clin Cancer Res
|
2013
|
0.75
|
|
27
|
Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil.
|
Chemotherapy
|
2008
|
0.75
|
|
28
|
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
|
Adv Anat Pathol
|
2017
|
0.75
|
|
29
|
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
|
Adv Anat Pathol
|
2017
|
0.75
|